behnam amani

This research was conducted with the aim of causal modeling of resilience based on basic psychological needs with the mediation of attachment styles in students from single-parent families.  The current research was carried out through the descriptive-correlation method (path analysis). The statistical population included all students studying in Mohaghegh Ardabili University in the first half of the 2018-2019 academic year. Among them, 170 people were selected using the available sampling method and answered the Basic Psychological Needs questionnaire of Ryan et al. (2000), Hazen et al.'s Attachment Styles (1987), and Connor et al.'s Resilience (2003). The obtained data were analyzed using structural equation modeling by smart pls3 software. The results showed that basic psychological needs had a direct and significant effect on resilience, and the indirect effect of basic psychological needs through the mediation of attachment styles was confirmed. The results of regression analysis showed that the predictive variables predicted about 30 % of the resilience variation. It is suggested that experts in the field of mental health use the findings of the present study in the framework of their educational and intervention programs, especially in working with children of single-parent families.

COVID-19 continues to pose a significant healthcare challenge throughout the world. This study aimed to investigate epidemiological characteristics and associated mortality factors among hospitalized patients with COVID-19 in the Mazandaran province.

In this descriptive study, the medical information of patients admitted to 39 hospitals in 17 cities in Mazandaran province between February 20, 2020, and February 20, 2021, were initially assessed and then entered the survey based on the study criteria. For data analysis, statistical approaches such as Chi-square and Fisher's exact test were performed at a significance level of 5%.

Out of the initial 34036 patients total patients, 21007 were included in the study with a mean age of 53.75±18.23 years, and 10219(48.6%) were males. The majority of cases and the highest mortality percent belonged to the age groups of 60 to 70 and 70 to 80. The Mortality proportion was 11.6% (n=2431), with a higher value in males than females. Moreover, the highest mortality rate was seen in ICU  (n=2803, 85.7%). Underlying diseases with the highest mortality rate were diabetes  (n=2058, 43%) and chronic heart disease  (n=166, 6.83%). The most common symptoms of illness were fever  (n=9025, 43%), hemoptysis  (n=5911, 28.10%), sore throat  (n=3771, 18%), and low blood pressure  (n=3626, 17.30%).

This study showed a high mortality rate among COVID-19 cases and dissected the related risk factors, including age, gender, underlying diseases, and ICU admission.

This study aims to compare combination therapy efficacy and safety with tamsulosin plus dutasteride versus tamsulosin in benign prostatic hyperplasia.

  An online search was conducted in PubMed, Cochrane Library, Embase, Scopus, and Web of Science to identify the relevant published studies up to July 2021. The reference list of the critical review articles was searched as well. The Cochrane risk of bias was used to assess the quality of studies. Meta-analysis was performed using the RevMan software v.5.3.

   Six studies, including 6647 patients, were included.  A  significant improvement was observed in the combination therapy group compared to the tamsulosin group in terms of international prostate symptom score (mean difference [MD]=-2.59, %95 confidence interval [CI]: -4.20 to -0.99; P=0.002), prostate volume (MD=-10.13, %95 CI: -12.38 to -7.88;  P<0.05), maximum urine flow rate (MD=1.05, %95 CI: 0.82 to 1.29; P<0.05), transitional zone volume (MD=-3.18, %95 CI: -3.57 to -2.79; P<0.05), and prostate-specific antigen (MD=-0.54, %95   CI: -0.80 to -0.29, P<0.05). The result of the subgroup showed that tamsulosin 0.2 mg in combination therapy was not effective in terms of international prostate symptom score (MD=-2.97; 95% CI: -7.49 to 1.56; P=0.20). Adverse events were more in combination therapy regarding erectile dysfunction, retrograde ejaculation, decreased libido, ejaculation failure, any adverse events, and any drug-related adverse event (P<0.05). However, there was no significant difference between the two groups regarding dizziness and any serious adverse event (P>0.05).

 This meta-analysis showed that combination therapy has greater efficacy in treating patients with benign prostatic hyperplasia; however, it is associated with higher adverse events

Erectile dysfunction is a common disease that has a significant negative impact on the quality of life of individuals. Low-intensity shockwave therapy (LI-ESWT) has been considered a new method for treating patients with erectile dysfunction.

To evaluate the safety and efficacy of LI-ESWT in the treatment of patients with erectile dysfunction.

A systematic review was conducted in the major databases, including PubMed, Cochrane Library, Embase, Scopus, and Web of Science up to February 2018. In order to find more articles, the reference list of the key review articles was searched as well. The quality of the studies was evaluated with the Cochrane Collaboration’s tools. The outcomes included The International Index of Erectile Function (IIEF), Erection Hardness Score (EHS), and adverse events. Meta-analysis was performed using RevMan software, version 5.3.

Seven randomized clinical trials involving 519 patients met the inclusion criteria. A significant improvement was observed in IIEF (mean difference [MD] = 4.54, 95% CI 0.44 - 8.63) and EHS (risk ratio [RR] = 2.99, 95% CI 1.16 - 7.70) in the intervention groups compared to the control groups. Sub-analysis showed that shockwave therapy significantly improved IIEF at 6, 9, and 10 weeks after the treatment (P < 0.05), and the EHS was improved at 5, 6, and 9 weeks (P < 0.05). There was also a significant improvement in the intervention groups in IIEF and EHS for 1500 and 3000 pulses, respectively (P < 0.05). No significant side effects were reported.

The findings of this study indicate LI-ESWT improves erectile dysfunction in patients, and it is safe and well-tolerated by patients.

The mortality rate index in the Intensive Care Unit (ICU) can be used to evaluate new treatments and specialist human resources and optimize resource allocation. Mortality in the ICUs of Iranian hospitals has been sporadically reported. The purpose of this study was to estimate the overall mortality rate of ICU patients in Iranian hospitals.

A systematic review was conducted in SID, MagIran, PubMed, Scopus, Web of Science, and Google Scholar for related articles until November 2019. Also, the reference lists of key studies were checked for additional citations. Quality assessment of studies was performed using the STROBE checklist. The results of the studies were analyzed using Comprehensive Meta-Analysis (CMA) software version 2.

Twenty-six studies involving 8980 patients were included in the review. The findings of the meta-analysis indicated that the overall mortality in ICU patients was 29.8% (95% CI, 0.259_0.34; P<.05). The prevalence of mortality in men and women was 29.8% (95% CI, 0.211_0.389; P<.05) and 29.2% (95% CI, 0.235_0.369; P<.05), respectively.

Mortality rate in ICU patients in Iranian hospitals is high compared to other countries. Therefore, resources and facilities should be considered in the ICUs.